For older adults with incidentally detected splenomegaly, a very large spleen volume predicts a substantial risk for ...
Incidentally detected spleen length ≥140 mm or volume ≥500 mL is linked to markedly increased hematologic cancer risk, ...
Conditional Survival and the Choice of Conditioning Set for Patients With Colon Cancer: An Analysis of NSABP Trials C-03 Through C-07 We retrospectively assessed the relationship between chemotherapy ...
Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions. Ojjaara (momelotinib) is the first treatment of ...
SAN DIEGO ― Combining the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing enlarged spleens – a major indicator of clinical improvement – compared with ...
Among previously untreated adults with Gaucher disease type 1, a genetic disease in which there is improper metabolism due to a defect in an enzyme, treatment with the drug eliglustat resulted in ...
Please provide your email address to receive an email when new articles are posted on . Pelabresib plus ruxolitinib conferred benefit to Janus kinase inhibitor-naive patients with myelofibrosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback